My PhD project concerns high-cost therapies and priority setting within a Norwegian context, with a focus on orphan drugs against rare diseases with a prevalence of <1:2000. The project applies both qualitative and quantitative methods in following orphan drugs from public deliberation to clinical rationing. Priority-setting is challenged by the high cost and long-term evidence uncertainty of orphan drugs. The aim is to gain knowledge on public preferences for orphan drugs and on the mechanisms for clinical rationing of orphan drugs. Findings will add to literature gaps and be relevant to clinicians, decision-makers, and patients.I started working with BCEPS through the Research Track/PhD programme in 2019-2020, during my medical degree. As a Research Track/PhD student at BCEPS, I lead the national Research Track conference, Frampeik, in Bergen in 2020/2021. In 2020, I was invited as a researcher to follow e-lectures at Harvard School of Public Health. I am expecting to finish the PhD by April 2026.

Editor in Chief for Paraplyen journal to Vestland county medical association. Paraplyen is printed four times a year to 4300 subscribing medical doctors and students. Paraplyen aims to provide its readers with relevant local and national health news, op-eds and regular columns from the professional associations comprising the board of the local medical association.